What is NTRS's health score?

NORTHERN TRUST CORP (NTRS) has a TradeApes health score of 53 out of 100, rated Mixed. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is NTRS's estimated fair value?

Based on our 5-year discounted cash flow model, NORTHERN TRUST CORP's estimated fair value is $93.05 per share, representing a -46.2% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is NTRS undervalued or overvalued?

Our model currently rates NTRS as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for NTRS... Refresh in a moment for the full analysis.

NORTHERN TRUST CORP (NTRS)

Financials Overvalued medium mixed

$173.06

Updated: 2026-06-05

TradeApes Score

Financial Strength

45 Mixed

Operating Trend

40 Weak

Relative Value

65 Healthy

Capital Allocation

50 Mixed

Risk

80 Strong

Est. Fair Value $93.05

DCF Upside -46.2%

Sector Rank #782 of 6130

Key Findings

+ High FCF yield — above 7%, strong cash return relative to price paid

Unlock Full Report →

− FCF deteriorating — free cash flow down more than 25% year over year

Unlock Full Report →

3 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.